News ArticleSEDEMAC Mechatronics Posts INR 39.18 Crore Profit on INR 400.64 Crore Revenue in Q2 FY2027
Board approves unaudited results showing half-year profit of INR 72.49 crore and total income of INR 711.88 crore for period ending September 30, 2026
SEDEMAC Mechatronics Limited announced unaudited financial results for Q2 and half year ended September 30, 2026, reporting a profit of INR 39.18 crore in the quarter on revenues of INR 400.64 crore. The half-year profit reached INR 72.49 crore with total income of INR 711.88 crore, as per their board meeting on November 3, 2026.
SEDEMAC Mechatronics Limited
Financial Results
SEDEMAC Mechatronics Limited declared its unaudited financial results for the quarter and half year ended September 30, 2026. The company recorded a quarterly profit of INR 39.18 crore on revenue from operations totaling INR 400.64 crore.
For the half year ended September 30, 2026, the company reported a total income of INR 711.88 crore and a profit of INR 72.49 crore.
Expenses including material costs, employee benefits, finance costs, depreciation and other expenses summed to INR 620.01 crore for the half year period.
The board meeting to approve these results was held on November 3, 2026, starting at 3:02 p.m. and concluding at 3:34 p.m.
The financials have been reviewed by B S R & Co. LLP, Chartered Accountants, who reported no material misstatements or disagreements with the accounting principles followed.
Highlights
- Quarterly revenue from operations of INR 400.64 crore for Q2 FY2027.
- Profit after tax for Q2 FY2027 stood at INR 39.18 crore.
- Half-year total income reached INR 711.88 crore with profit of INR 72.49 crore.
- Total expenses for half year were INR 620.01 crore.
- Board meeting held and results approved on November 3, 2026.
- Limited review by independent auditor B S R & Co. LLP with no exceptions noted.
Key Data Snapshot
What happened
- SEDEMAC Mechatronics Limited announced unaudited results for Q2 and half year ended 30 September 2026.
- The board approved the financial statements in a meeting held on 3 November 2026.
Financial performance
- Revenue from operations for the quarter was INR 400.64 crore, increasing total income to INR 401.25 crore including other income.
- Profit after tax for the quarter was INR 39.18 crore.
- For the half year, total income was INR 711.88 crore and net profit was INR 72.49 crore.
- Total expenses for the half year period amounted to INR 620.01 crore, including employee benefits, material costs, finance costs, depreciation and other expenses.
Regulatory and governance context
- Financial results are prepared in accordance with Indian Accounting Standard 34 and SEBI Listing Regulations.
- Results have undergone limited review by B S R & Co. LLP with no material misstatements found.
Highlights
- Quarterly revenue from operations of INR 400.64 crore for Q2 FY2027.
- Profit after tax for Q2 FY2027 stood at INR 39.18 crore.
- Half-year total income reached INR 711.88 crore with profit of INR 72.49 crore.
- Total expenses for half year were INR 620.01 crore.
- Board meeting held and results approved on November 3, 2026.
- Limited review by independent auditor B S R & Co. LLP with no exceptions noted.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Indian Accounting Standard 34 (Ind AS 34)
Source Information
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Biocon Limited Reports Rs. 1,439 Million Profit for H1 FY2026-27; Appoints Mukesh Rathi as New CTO from January 2027
Biocon Limited declared its unaudited standalone financial results for the quarter and half-year ended September 30, 2026, reporting a profit of Rs. 1,439 million for the half-year. Alongside financial disclosure, the company announced a change in its senior management with the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as the new CTO starting January 1, 2027.
Read Full Story
Zydus Lifesciences Posts ₹10,541 Million Net Profit for Half Year Ending September 30, 2026
Zydus Lifesciences Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, recording a net profit of ₹7,145 million for Q2 and ₹10,541 million for the half year.
Read Full Story
Fractal Analytics Limited Reports Unaudited Q2 and H1 2026 Financial Results and Approves Winding Up of Analytics Vidhya Inc
Fractal Analytics Limited announced its unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026. Additionally, the company's Board has approved winding up its step-down subsidiary Analytics Vidhya Inc., aiming to simplify group corporate structure and enhance operational efficiency without affecting ongoing business activities.
Read Full Story
